UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection

Clinical trial NCT04406727 · UNKNOWN

Trial details

NCT number: NCT04406727
Sponsor: United BioPharma
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2023-12-01
Primary completion: 2026-06-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.